JOHNSON & JOHNSON MEDICAL LIMITED
Get an alert when JOHNSON & JOHNSON MEDICAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-05-29 (this month)
Last made up 2025-05-15
Watchouts
None on the register
Cash
£4M
-51.8% vs 2023
Net assets
£542M
+6.1% vs 2023
Employees
1,344
+13.3% vs 2023
Profit before tax
£47M
-11.6% vs 2023
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-29
Latest accounts filed cover 2024-12-31; financial figures currently reflect up to 2024-12-29.
| Metric | Trend | 2023-12-31 | 2024-12-29 |
|---|---|---|---|
| Turnover | £602,164,000 | £654,587,000 | |
| Operating profit | £32,938,000 | £33,745,000 | |
| Profit before tax | £52,616,000 | £46,512,000 | |
| Net profit | £37,911,000 | £34,411,000 | |
| Cash | £8,890,000 | £4,285,000 | |
| Total assets less current liabilities | £592,950,000 | £676,006,000 | |
| Net assets | £510,662,000 | £541,574,000 | |
| Equity | £510,662,000 | £541,574,000 | |
| Average employees | 1,186 | 1,344 | |
| Wages | £124,885,000 | £131,647,000 | |
| Directors' remuneration | £1,162,000 | £910,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-29 vs 2023-12-31
-
Turnover
+8.7%
£602,164,000 £654,587,000
-
Cash
-51.8%
£8,890,000 £4,285,000
-
Net assets
+6.1%
£510,662,000 £541,574,000
-
Employees
+13.3%
1,186 1,344
-
Operating profit
+2.5%
£32,938,000 £33,745,000
-
Profit before tax
-11.6%
£52,616,000 £46,512,000
-
Wages
+5.4%
£124,885,000 £131,647,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Heads up: a more recent set of accounts has been filed but isn't yet reflected here — the figures above are older than the company's latest filing.
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-29 |
|---|---|---|---|
| Operating margin | 5.5% | 5.2% | |
| Net margin | 6.3% | 5.3% | |
| Return on capital employed | 5.6% | 5.0% | |
| Gearing (liabilities / total assets) | 42.9% | 43.7% | |
| Current ratio | 1.08x | 1.31x | |
| Interest cover | 13.38x | 4.89x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 3 times since incorporation
- JOHNSON & JOHNSON MEDICAL LIMITED 2004-05-25 → present
- JOHNSON AND JOHNSON MEDICAL LIMITED 2004-03-15 → 2004-05-25
- ETHICON LIMITED 1991-09-06 → 2004-03-15
- ARRIVEDEAL LIMITED 1991-05-31 → 1991-09-06
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors believe it is reasonable to assume that the Company will have adequate resources for a period of 12 months (the "Assessment Period") from the date of approval of these financial statements to discharge its obligations as they fall due.”
Group structure
- JOHNSON & JOHNSON MEDICAL LIMITED · parent
- DePuy International Limited 100%
- DePuy Hellas S.A. 100%
Significant events
- “In May 2025, the company received dividends amounting to £30,000,000 from its subsidiary company, Depuy International Limited. On 14th October 2025, Johnson & Johnson announced its intention to separate its orthopaedics business to enhance the strategic and operational focus of each company and drive value for stakeholders.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 44 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BAGNALL, Angela Rose | Director | 2026-01-22 | Aug 1979 | American |
| BAXTER, Harry, Mr. | Director | 2026-04-20 | Apr 1986 | British |
| DALTON, Andrew Malcolm | Director | 2022-09-23 | Jun 1973 | British |
| FERRANTE, Franco, Mr. | Director | 2026-04-20 | Apr 1978 | British |
| LANTZ, Barbara | Director | 2023-09-01 | Sep 1977 | French |
| WHITING, Samantha Jane, Ms. | Director | 2026-04-20 | Dec 1974 | British |
Show 44 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FABER, Abraham Andries | Secretary | 2006-01-01 | 2011-06-29 |
| PAYNE, Robert | Secretary | 1991-08-05 | 2005-03-31 |
| PLATT, Frederick | Secretary | 2005-04-01 | 2005-12-31 |
| ROSE, Douglas Alfred Peter | Secretary | 2011-06-29 | 2018-06-29 |
| OSWALDS OF EDINBURGH LIMITED | Corporate Nominee Secretary | 1991-05-31 | 1991-08-05 |
| ABRUZZINI, Giovanni | Director | 2017-06-05 | 2019-06-18 |
| AMIN, Chirag | Director | 2024-07-01 | 2025-03-13 |
| BARREAU, Stephen Eugene | Director | 2017-06-12 | 2020-11-02 |
| BINNIE, David Orr Smith | Director | 1991-08-05 | 1997-12-31 |
| BLAIR, George Moore | Director | 2016-04-06 | 2017-11-06 |
| BORTHWICK, George Cooper, Professor | Director | 1991-08-27 | 2002-03-31 |
| BREDA, Hugo | Director | 2019-04-05 | 2024-08-20 |
| BROWNING, James Jonathan | Director | 1994-10-01 | 2000-06-12 |
| BUCKINGHAM, Ian Ronald | Director | 1992-07-01 | 2000-01-01 |
| CAPPERAULD, Ian | Director | 1991-08-05 | 1994-05-01 |
| CARNE, Philip | Director | 1991-08-27 | 1999-03-01 |
| CLEWORTH, Andrew | Director | 2022-09-23 | 2023-08-31 |
| COLLINGS, Bruce Charles | Director | 1993-01-01 | 1997-12-31 |
| CRAWFORD, Graeme Gilmour | Director | 1991-08-05 | 1997-12-31 |
| DUTILLOY, Sophie Jeanne | Director | 2012-10-08 | 2015-11-02 |
| EASTON, Sandra | Director | 2021-07-05 | 2023-08-31 |
| FABER, Abraham Andries | Director | 2006-01-01 | 2014-03-04 |
| FAGAN, Gerard | Director | 1991-08-05 | 1997-06-13 |
| FOLLOWS, David Mark | Director | 2010-07-01 | 2011-03-31 |
| FOLLOWS, David Mark | Director | 2004-07-19 | 2007-06-28 |
| FOLLOWS, David Mark | Director | 2000-01-01 | 2002-12-31 |
| GRANT, Rosemary | Director | 2007-09-03 | 2010-07-01 |
| HOUSE, Timothy James | Director | 2019-09-27 | 2020-11-30 |
| LAVERY, Thomas Robin | Director | 2012-10-08 | 2019-03-01 |
| MARTIN BEVERAGGI, Ricardo Arturo, Mr. | Director | 2024-08-20 | 2026-01-21 |
| MCCRACKEN, Derek Sinclair | Director | 1991-08-27 | 1997-06-30 |
| MCLEAN, James Angus | Director | 2021-03-01 | 2021-07-05 |
| MORGAN, Colin Steel | Director | 1995-06-01 | 2012-11-28 |
| MORGAN, Colin Steel | Director | 1991-08-27 | 1992-12-31 |
| NAGY, Jennifer Marie | Director | 2023-11-01 | 2024-06-20 |
| NORMAN, Christopher Keith | Director | 2011-06-29 | 2011-12-01 |
| PLATT, Frederick | Director | 2004-07-19 | 2005-12-31 |
| POTARINA, Victoria | Director | 2017-08-04 | 2018-01-08 |
| PRINTIE, William John | Director | 2000-01-01 | 2004-12-10 |
| SVEEN, Jakob | Director | 2020-01-01 | 2023-12-12 |
| THOM, Anne Jennifer, Dr | Director | 1995-06-26 | 1997-11-07 |
| TIGHE, Fionnuala Maria | Director | 2014-03-04 | 2021-03-01 |
| WALKER, Ian Blyth Lathangie | Director | 2012-10-08 | 2024-12-20 |
| JORDANS (SCOTLAND) LIMITED | Corporate Nominee Director | 1991-05-31 | 1991-08-05 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Johnson & Johnson Management Limited | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 196 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-22 | AP01 | officers | Appoint person director company with name date | |
| 2026-04-22 | AP01 | officers | Appoint person director company with name date | |
| 2026-04-22 | AP01 | officers | Appoint person director company with name date | |
| 2026-01-27 | AP01 | officers | Appoint person director company with name date | |
| 2026-01-22 | TM01 | officers | Termination director company with name termination date | |
| 2025-12-16 | AA | accounts | Accounts with accounts type full | |
| 2025-05-26 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-03-18 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-07 | TM01 | officers | Termination director company with name termination date | |
| 2024-12-16 | AA | accounts | Accounts with accounts type full | |
| 2024-08-27 | AP01 | officers | Appoint person director company with name date | |
| 2024-08-23 | TM01 | officers | Termination director company with name termination date | |
| 2024-07-03 | AP01 | officers | Appoint person director company with name date | |
| 2024-07-02 | TM01 | officers | Termination director company with name termination date | |
| 2024-05-15 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-01-09 | TM01 | officers | Termination director company with name termination date | |
| 2023-11-08 | AA | accounts | Accounts with accounts type full | |
| 2023-11-02 | AP01 | officers | Appoint person director company with name date | |
| 2023-10-24 | TM01 | officers | Termination director company with name termination date | |
| 2023-09-28 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 7
- Capital events
- 0
- Officers appointed
- 4
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.